Digital Sponsored How pharma marketing can stay ahead of the evolving customer... Overview View our webinar which took place on Tuesday 23rd July at 16:00 BST / 11:00 EST / 08:00 PST.
News Gilead's twice-yearly PrEP drug is cleared by FDA Gilead has FDA approval for a twice-yearly PrEP drug, but could proposed cuts to US funding for HIV prevention programmes hinder its take-up?
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face